Functional Analysis of the Lipoglycodepsipeptide Antibiotic Ramoplanin

Slides:



Advertisements
Similar presentations
Patrick Groves, Mark S Searle, Joel P Mackay, Dudley H Williams 
Advertisements

Structure of TAR RNA Complexed with a Tat-TAR Interaction Nanomolar Inhibitor that Was Identified by Computational Screening  Zhihua Du, Kenneth E Lind,
Volume 12, Issue 10, Pages (October 2005)
The loop E–loop D region of Escherichia coli 5S rRNA: the solution structure reveals an unusual loop that may be important for binding ribosomal proteins 
Solution Structure of ZASP PDZ Domain
Volume 9, Issue 2, Pages (February 2002)
Volume 108, Issue 1, Pages (January 2015)
Volume 9, Issue 10, Pages (October 2002)
Christopher A. Hunter, Salvador Tomas  Chemistry & Biology 
Volume 22, Issue 10, Pages (October 2014)
Volume 13, Issue 12, Pages (December 2005)
Volume 19, Issue 10, Pages (October 2012)
Volume 115, Issue 2, Pages (October 2003)
Volume 24, Issue 12, Pages (December 2016)
Tamas Yelland, Snezana Djordjevic  Structure 
Yvonne Groemping, Karine Lapouge, Stephen J. Smerdon, Katrin Rittinger 
De Novo Design of α-Amylase Inhibitor: A Small Linear Mimetic of Macromolecular Proteinaceous Ligands  Lucie Dolečková-Marešová, Manfred Pavlík, Martin.
Volume 6, Issue 8, Pages (August 1998)
Michael Adrian, Fernaldo Richtia Winnerdy, Brahim Heddi, Anh Tuân Phan 
Volume 108, Issue 6, Pages (March 2015)
Structure of the TPR Domain of p67phox in Complex with Rac·GTP
Volume 11, Issue 7, Pages (July 2003)
Volume 19, Issue 7, Pages (July 2011)
Volume 108, Issue 1, Pages (January 2015)
Structure and RNA Interactions of the N-Terminal RRM Domains of PTB
Nadine Keller, Jiří Mareš, Oliver Zerbe, Markus G. Grütter  Structure 
Sunny D. Gilbert, Francis E. Reyes, Andrea L. Edwards, Robert T. Batey 
Crystal Structures of Oligomeric Forms of the IP-10/CXCL10 Chemokine
Solution and Crystal Structures of a Sugar Binding Site Mutant of Cyanovirin-N: No Evidence of Domain Swapping  Elena Matei, William Furey, Angela M.
Interactions between Charged Polypeptides and Nonionic Surfactants
Leonardus M.I. Koharudin, Angela M. Gronenborn  Structure 
Targeting Apoptosis via Chemical Design
Nicholas J Skelton, Cliff Quan, Dorothea Reilly, Henry Lowman 
Volume 114, Issue 5, Pages (March 2018)
A Conformational Switch in the CRIB-PDZ Module of Par-6
Volume 18, Issue 6, Pages (June 2010)
Graham D. Bailey, Jae K. Hyun, Alok K. Mitra, Richard L. Kingston 
Volume 20, Issue 1, Pages (January 2013)
The Structure of the Tiam1 PDZ Domain/ Phospho-Syndecan1 Complex Reveals a Ligand Conformation that Modulates Protein Dynamics  Xu Liu, Tyson R. Shepherd,
Comparative Molecular Dynamics Simulation Studies of Protegrin-1 Monomer and Dimer in Two Different Lipid Bilayers  Huan Rui, Jinhyuk Lee, Wonpil Im 
Volume 13, Issue 2, Pages (February 2005)
Volume 23, Issue 6, Pages (June 2015)
Structural Basis for the Recognition of Methylated Histone H3K36 by the Eaf3 Subunit of Histone Deacetylase Complex Rpd3S  Chao Xu, Gaofeng Cui, Maria.
Patrick Groves, Mark S Searle, Joel P Mackay, Dudley H Williams 
Volume 19, Issue 1, Pages (January 2011)
Volume 13, Issue 12, Pages (December 2005)
Molecular Interactions of Alzheimer's Biomarker FDDNP with Aβ Peptide
Meigang Gu, Kanagalaghatta R. Rajashankar, Christopher D. Lima 
Volume 24, Issue 5, Pages (May 2016)
Mechanisms Contributing to T Cell Receptor Signaling and Assembly Revealed by the Solution Structure of an Ectodomain Fragment of the CD3ϵγ Heterodimer 
Volume 11, Issue 8, Pages (August 2003)
Volume 35, Issue 3, Pages (August 2009)
Structure of the Staphylococcus aureus AgrA LytTR Domain Bound to DNA Reveals a Beta Fold with an Unusual Mode of Binding  David J. Sidote, Christopher.
Volume 24, Issue 7, Pages (July 2016)
Structural Basis of Swinholide A Binding to Actin
Volume 16, Issue 6, Pages (June 2008)
Volume 110, Issue 9, Pages (May 2016)
Volume 22, Issue 10, Pages (October 2014)
Volume 20, Issue 2, Pages (February 2013)
Volume 18, Issue 3, Pages (March 2011)
Volume 113, Issue 3, Pages (August 2017)
Volume 18, Issue 9, Pages (September 2010)
Structure and Interactions of PAS Kinase N-Terminal PAS Domain
Mike O'Donnell, David Jeruzalmi, John Kuriyan  Current Biology 
Characterization of Structure, Dynamics, and Detergent Interactions of the Anti-HIV Chemokine Variant 5P12-RANTES  Maciej Wiktor, Oliver Hartley, Stephan.
Volume 14, Issue 12, Pages (December 2006)
Volume 13, Issue 6, Pages (June 2006)
Volume 19, Issue 4, Pages (April 2011)
Crystal Structure of Hyaluronidase, a Major Allergen of Bee Venom
Volume 97, Issue 5, Pages (September 2009)
Presentation transcript:

Functional Analysis of the Lipoglycodepsipeptide Antibiotic Ramoplanin Predrag Cudic, Douglas C Behenna, James K Kranz, Ryan G Kruger, A.Joshua Wand, Yuri I Veklich, John W Weisel, Dewey G McCafferty  Chemistry & Biology  Volume 9, Issue 8, Pages 897-906 (August 2002) DOI: 10.1016/S1074-5521(02)00191-6

Figure 1 Chemical Structures of the Antibiotic Ramoplanin Factor A2 from Actinoplanes ATCC 33076, the Semisynthetic Ramoplanin Analogs Prepared in This Study, and the Structurally Related Enduracidin Antibiotics from Streptomyces fungicidicus B5477 Common structural elements of the sequences of ramoplanin and enduracidins are colored blue. Divergent structural elements are colored red. Highlighted in yellow are the amino acid residues that exhibit marked NMR chemical shift changes upon binding PG precursors [16]. A similar sequence is found in the enduracidins. Nonstandard residues are denoted as follows: Chp, 3-chloro-4-hydroxyphenylglycine; Cit, citrulline; Dpg, 3,5-dichloro-4-hydroxyphenylglycine; End, enduracididine; Hpg, 4-hydroxyphenylglycine. Chemistry & Biology 2002 9, 897-906DOI: (10.1016/S1074-5521(02)00191-6)

Figure 2 Chemical Structures of Synthetic and Naturally Occurring Analogs of Bacterial Peptidoglycan Monomers Used in This Study Chemistry & Biology 2002 9, 897-906DOI: (10.1016/S1074-5521(02)00191-6)

Figure 3 Transmission Electron Micrograph of the Aggregate Formed from the Complexation of Enduracidin with Compound 10 Chemistry & Biology 2002 9, 897-906DOI: (10.1016/S1074-5521(02)00191-6)

Figure 4 NMR Analysis of Peptidoglycan Biosynthesis Intermediate Complexation by Ramoplanin Aglycon (2) (A) Part of the aliphatic region of the 1H NMR spectrum of free ramoplanin aglycon (2), free Park's nucleotide (11), and a 1:1 mixture of the two illustrating the chemical shift changes that occur upon binding. (B) Representative transmision electron micrograph of the fibrils formed from the complexation of aglycon 2 with Park's nucleotide (11). Fibrils formed from the interaction of ramoplanin (1) or its derivatives 2–4 with citronellyl-Lipid I (10) and Park's nucleotide (11), respectively, exhibited similar morphology. (C) Representative Kd determination plot of the binding of ramoplanin aglycon (2) to Park's nucleotide (11) as obtained by 1H NMR titration. The curve denotes the experimental (open circles) and calculated (solid line) chemical shifts (δ) of the lactyl ether methyl protons (3a) of 11 as a function of ramoplanin concentration. Chemistry & Biology 2002 9, 897-906DOI: (10.1016/S1074-5521(02)00191-6)

Figure 5 Interaction of [Orn4,Orn10]-Diguanidylated Ramoplanin with Park's Nucleotide (A) Aromatic and amide region of the 1H NMR spectrum of free [Orn4,Orn10]-diguanidylated ramoplanin (3). The spectrum was obtained at 500 MHz at 25°C in D2O (pH 6.0). (B) The same aromatic and amide region of the 1H NMR spectrum of [Orn4,Orn10]-diguanidylated ramoplanin (3) with equimolar Park's nucleotide (11) depicting the line broadening and chemical shift changes that occur upon binding. (C) Isothermal titration calorimetry data from the titration of [Orn4,Orn10]-diguanidylated ramoplanin (3) with compound 11. The complex pattern of heat released during the titration is indicative of ligand-induced aggregation [46, 47]. Chemistry & Biology 2002 9, 897-906DOI: (10.1016/S1074-5521(02)00191-6)

Figure 6 Design and Biophysical Analysis of a Ramoplanin-Derived Cyclic Peptide that Binds a Peptidoglycan Biosynthesis Intermediate (A) Surface representation of ramoplanin (1) based on the NMR solution structure obtained in 20% DMSO [35]. Residues participating in capture of peptidoglycan monomer/lipid intermediates identified by NMR analysis are colored in yellow and lie on one face of the antibiotic surface. (B) Stick representation of the structure of ramoplanin showing that the residues comprising the binding interface lie along one of the two β strands eminating from the Thr8-Phe9 type I β turn. (C) Covalent structure of a disulfide-linked conformationally constrained peptide designed to mimic structural and functional elements of ramoplanin's peptidoglycan intermediate capture motif. (D) Part of the aliphatic region of the 1H NMR spectrum of free peptide 16 (cyclic disulfide form, bottom trace), free Park's nucleotide (11, top trace), and a 1:1 mixture of the two (middle trace) depicting the chemical shift changes that occur upon binding. (E) Plot of binding of peptide 16 to Park's nucleotide (11) as obtained by 1H NMR titration. The solid circles denote the chemical shifts (δ) of the lactyl ether methyl protons (3a) of 11 as a function of the concentration of 16. Chemistry & Biology 2002 9, 897-906DOI: (10.1016/S1074-5521(02)00191-6)